Autolus Therapeutics plc (AUTL)

Autolus Therapeutics Revenue

Autolus Therapeutics had revenue of $10.50M in the twelve months ending March 31, 2024, with 40.22% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $10.09M with 681.04% year-over-year growth. In the year 2023, Autolus Therapeutics had annual revenue of $1.70M, a decrease of -73.30%.

• Revenue (ttm): $10.50M
• Revenue Growth: +40.22%
• P/S Ratio: 85.66
• Revenue / Employee: $22,672
• Employees: 463
• Market Cap: 899.20M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.70M	-4.66M	-73.30%
Dec 31, 2022	6.36M	4.03M	172.96%
Dec 31, 2021	2.33M	615.00K	35.86%
Dec 31, 2020	1.72M	-1.19M	-41.02%
Dec 31, 2019	2.91M	1.50M	106.68%
Sep 30, 2018	1.41M	-286.00K	-16.89%
Sep 30, 2017	1.69M	481.00K	39.69%
Sep 30, 2016	1.21M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.